Skip to main content

Volume 11 Supplement 9

Selected Proceedings of the 2010 AMIA Summit on Translational Bioinformatics

Proceedings

Edited by Eneida A Mendoça

2010 AMIA Summit on Translational Bioinformatics.

San Francisco, CA, USA10-12 March 2010

  1. Identification of expression quantitative trait loci (eQTLs) is an emerging area in genomic study. The task requires an integrated analysis of genome-wide single nucleotide polymorphism (SNP) data and gene exp...

    Authors: Hsun-Hsien Chang, Michael McGeachie, Gil Alterovitz and Marco F Ramoni

    Citation: BMC Bioinformatics 2010 11(Suppl 9):S2

    Content type: Proceedings

    Published on:

  2. Given the rapid growth of translational research and personalized healthcare paradigms, the ability to relate and reason upon networks of bio-molecular and phenotypic variables at various levels of granularity...

    Authors: Philip RO Payne, Kun Huang, Kristin Keen-Circle, Abhisek Kundu, Jie Zhang and Tara B Borlawsky

    Citation: BMC Bioinformatics 2010 11(Suppl 9):S3

    Content type: Proceedings

    Published on:

  3. Diagnosis and treatment of patients in the clinical setting is often driven by known symptomatic factors that distinguish one particular condition from another. Treatment based on noticeable symptoms, however,...

    Authors: David P Chen, Joel T Dudley and Atul J Butte

    Citation: BMC Bioinformatics 2010 11(Suppl 9):S4

    Content type: Proceedings

    Published on:

  4. Chronic lymphocytic leukemia (CLL) is the most common adult leukemia. It is a highly heterogeneous disease, and can be divided roughly into indolent and progressive stages based on classic clinical markers. Im...

    Authors: Jie Zhang, Yang Xiang, Liya Ding, Kristin Keen-Circle, Tara B Borlawsky, Hatice Gulcin Ozer, Ruoming Jin, Philip Payne and Kun Huang

    Citation: BMC Bioinformatics 2010 11(Suppl 9):S5

    Content type: Proceedings

    Published on:

  5. Combining the results of studies using highly parallelized measurements of gene expression such as microarrays and RNAseq offer unique challenges in meta analysis. Motivated by a need for a deeper understandin...

    Authors: Alexander A Morgan, Purvesh Khatri, Richard Hayden Jones, Minnie M Sarwal and Atul J Butte

    Citation: BMC Bioinformatics 2010 11(Suppl 9):S6

    Content type: Proceedings

    Published on:

  6. A key challenge in pharmacogenomics is the identification of genes whose variants contribute to drug response phenotypes, which can include severe adverse effects. Pharmacogenomics GWAS attempt to elucidate ge...

    Authors: Nicholas P Tatonetti, Joel T Dudley, Hersh Sagreiya, Atul J Butte and Russ B Altman

    Citation: BMC Bioinformatics 2010 11(Suppl 9):S9

    Content type: Proceedings

    Published on:

  7. In pursuing personalized medicine, pharmacogenomic (PGx) knowledge may help guide prescribing drugs based on a person’s genotype. Here we evaluate the feasibility of incorporating PGx knowledge, combined with ...

    Authors: Casey Lynnette Overby, Peter Tarczy-Hornoch, James I Hoath, Ira J Kalet and David L Veenstra

    Citation: BMC Bioinformatics 2010 11(Suppl 9):S10

    Content type: Proceedings

    Published on:

  8. Mouse xenograft models, in which human cancer cells are implanted in immune-suppressed mice, have been popular for studying the mechanisms of novel therapeutic targets, tumor progression and metastasis. We hyp...

    Authors: Xinan Yang, Younghee Lee, Yong Huang, James L Chen, Rosie H Xing and Yves A Lussier

    Citation: BMC Bioinformatics 2010 11(Suppl 9):S11

    Content type: Proceedings

    Published on:

  9. In humans, copies of the Long Interspersed Nuclear Element 1 (LINE-1) retrotransposon comprise 21% of the reference genome, and have been shown to modulate expression and produce novel splice isoforms of trans...

    Authors: Eric Rouchka, Diego E Montoya-Durango, Vilius Stribinskis, Kenneth Ramos and Ted Kalbfleisch

    Citation: BMC Bioinformatics 2010 11(Suppl 9):S12

    Content type: Proceedings

    Published on:

  • Editorial Board
  • Sign up for article alerts and news from this journal
  • As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

2019 Journal Metrics

  • Citation Impact
    3.242 - 2-year Impact Factor
    3.213 - 5-year Impact Factor
    1.156 - Source Normalized Impact per Paper (SNIP)
    1.626 - SCImago Journal Rank (SJR)

    Usage 
    4,058,323 downloads

    Social Media Impact
    6067 mentions